Michael Holder

Michael B. Holder is currently an Independent Director at Cytek Biosciences, Inc. since 2024, a Director at Keyron Ltd. since 2022, and an Independent Director at MDxHealth SA starting in 2025.
Former roles include Chief Executive Officer at Sensable Health, Chairman, President & Chief Executive Officer at Novation Holdings, Inc. from 2011 to 2012, Chairman, Chief Executive & Financial Officer at Organ Transport Systems, Inc. from 2010 to 2017, Director at Alternative Energy Partners, Inc., Director at Limitless LLC from 2018 to 2019, Director at Cyphre Security Solutions LLC from 2016 to 2017, Principal at AMR Corp., Principal at Premier Healthcare Solutions, Inc., Chief Financial Officer at BeaconEye, Inc., Vice President at Heartland Capital Partners LLC, Chief Financial Officer at AVITA Medical, Inc. from 2021 to 2023, Chief Financial Officer at Immunecyte, Inc. from 2020 to 2021, and Chief Financial Officer at Clarkston Consulting, Inc. from 1998 to 2000.
Education includes undergraduate studies at Kenan-Flagler Business School and an MBA from The Wharton School of the University of Pennsylvania.